Renal cancer cells with PTPN22 knockdown exhibited reduced green fluorescence, indicating that PTPN22 silencing diminishes the capacity of cancer cells to bind PD-1 by lowering PD-L1 levels; this effect was reversed by PD-L1 overexpression (Figure S3A, B). This evidence concerns the gene PTPN22 and cancer.